Inhibition of cyclooxygenase-1 or -2 on insulin sensitivity in healthy subjects

Hormone and Metabolic Research

Volumn 33, Issue 4, 2001, Pages 250-253

  Gonzalez Ortiz M ^a   Martinez Abundis E ^a   Balcazar Munoz B R ^a   Robles Cervantes, J A ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

COX; Cyclooxygenase 1; Cyclooxygenase 2; Insulin action; Insulin sensitivity; Insulin tolerance test

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CHOLESTEROL; CREATININE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; URIC ACID; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG CONTRAINDICATION; ENZYME INHIBITION; HUMAN; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ASPIRIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DOUBLE-BLIND METHOD; HUMANS; INSULIN; INSULIN RESISTANCE; ISOENZYMES; MALE; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; REFERENCE VALUES; SULFONAMIDES;

EID: 0035000130     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-14949     Document Type: Article

References (15)

1. Jouzeau J-Y, Terlain B, Abid A, Nédélec E, Netter P. Cyclooxygenase isoenzymes. Drug 1977; 53: 563-582
2. Lipsky PE, Abramson SB, Crofford L, Dubois RN, Simon LS, Van de Putte LBA. The classification of cyclooxygenase inhibitors. J Rheumatol 1998; 25: 2298-2303
3. Newsholme EA. Some experiments on factors that can change insulin sensitivity. Ann Med 1990; 22: 181-184
4. Leighton B, Chaliss RAJ, Newsholme EA. The role of prostaglandins as modulators of insulin-stimulated glucose metabolism in skeletal muscle. Horm Metab Res 1990; 22 (Suppl.): 89-95
5. Wasner HK, Weber S, Partke HJ, Amini-Hadi-Kiashar H. Indomethacin treatment causes loss of insulin action in rats: involvement of prostaglandins in the mechanism of insulin action. Acta Diabetol 1994; 31: 175-182
6. Paolisso G, Gambardella A, Saccomanno F, Varricchio G, D'Amore A, Varricchio M. Low-dose iloprost infusion improves insulin action and non-oxidative glucose metabolism in hypertensive patients. Eur J Clin Pharmacol 1995; 48: 333-338
7. González-Ortiz M, Martínez-Abundis E, Escalante-Pulido JM. Comparison of homeostasis model analysis with insulin tolerance test in the assessment of insulin resistance in healthy young people. Diab Nutr Metab 1998; 11: 136-139
8. Summers SA, Yin VP, Whiteman EL, Garza LA, Cho H, Tuttle RL, Birnbaum MJ. Signaling pathways mediating insulin-stimulated glucose transport. Ann N Y Acad Sci 1999; 892: 69-186
9. Robertson P. Dominance of cyclooxygenase-2 in the regulation of pancreatic islet prostaglandin synthesis. Diabetes 1998; 47: 379-1383
10. Meade EA, Smith WL, DeWitt DL. Diferential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1993; 268: 6610-6614
11. Green A, Walters DJ, Belt SE. Insulin resistance in adipocytes after downregulation of Gi subtypes. Am J Physiol 1997; 273: E254-E261
12. Virkamäki A, Yki-Järvinen H. Role of prostaglandins in mediating alterations in glucose metabolism during acute endotoxemia in the rat. Endocrinology 1995; 136: 701 -1706
13. Salazar-Páramo M, González-Ortiz M, González-López L, Sánchez-Ortiz A, Valera-González IC, Martínez-Abundis E, Balcázar-Muñoz BR, García-González A, Gámez-Nava JI. Serum leptin levels in patients with rheumatoid arthritis. J Clin Rheumatol 2001; 7: 57-60
14. González-Ortiz M, Martínez-Abundis E, Pascoe-González S. Comparison between usual and low doses of insulin in the assessment of insulin sensitivity with a short insulin tolerance test in obese women. Arch Med Res 1999; 30: 385-387
15. Suzuki M, Ikebuchi M, Shinozaki K, Hara Y, Tsushima M, Matsuyama T, Harano Y. Mechanism and clinical implication of insulin resistance syndrome. Diabetes 1996; 45 (Suppl. 3): S52-S54